Detalles de la búsqueda
1.
Safety and efficacy of filgotinib, lanraplenib and tirabrutinib in Sjögren's syndrome: a randomized, phase 2, double-blind, placebo-controlled study.
Rheumatology (Oxford)
; 61(12): 4797-4808, 2022 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35377447
2.
Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial.
Ann Rheum Dis
; 80(7): 848-858, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33504485
3.
Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial.
Ann Rheum Dis
; 80(6): 727-738, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33452004
4.
Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial.
Lancet
; 392(10162): 2367-2377, 2018 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30360969
5.
Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial.
Lancet
; 392(10162): 2378-2387, 2018 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30360970
6.
Effect of Filgotinib vs Placebo on Clinical Response in Patients With Moderate to Severe Rheumatoid Arthritis Refractory to Disease-Modifying Antirheumatic Drug Therapy: The FINCH 2 Randomized Clinical Trial.
JAMA
; 322(4): 315-325, 2019 07 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-31334793
7.
Sjögren's syndrome: managed care data from a large United States population highlight real-world health care burden and lack of treatment options.
Clin Exp Rheumatol
; 35(1): 98-107, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-27749234
8.
Phase 2b randomized trial of OX40 inhibitor telazorlimab for moderate-to-severe atopic dermatitis.
J Allergy Clin Immunol Glob
; 3(1): 100195, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38187863
9.
A multicenter, open-label, efficacy, pharmacokinetic, and safety study of adalimumab in Japanese patients with ankylosing spondylitis.
Mod Rheumatol
; 22(4): 589-97, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22205117
10.
Randomized, double-blind, placebo-controlled trial of ISC 17536, an oral inhibitor of transient receptor potential ankyrin 1, in patients with painful diabetic peripheral neuropathy: impact of preserved small nerve fiber function.
Pain
; 163(6): e738-e747, 2022 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34490850
11.
Satisfaction with control of systemic lupus erythematosus and lupus nephritis: physician and patient perspectives.
Patient Prefer Adherence
; 10: 2051-2061, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27784995
12.
Clinical, functional, and radiographic implications of time to treatment response in patients with early rheumatoid arthritis: a posthoc analysis of the PREMIER study.
J Rheumatol
; 41(2): 235-43, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24293583
13.
Clinical, functional, and radiographic benefits of longterm adalimumab plus methotrexate: final 10-year data in longstanding rheumatoid arthritis.
J Rheumatol
; 40(9): 1487-97, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23818718
14.
Efficacy, pharmacokinetics, and safety of adalimumab in pediatric patients with juvenile idiopathic arthritis in Japan.
Clin Rheumatol
; 31(12): 1713-21, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23053683
Resultados
1 -
14
de 14
1
Próxima >
>>